Abstract
Expression of the urokinase-type plasminogen activator (uPA) is under tight regulation by hormones, cytokines and growth factors under physiological conditions. Treatment of lung epithelial (Beas2B) cells with translation inhibitors induces uPA mRNA expression, as well as early response genes. To understand the specific expression and regulation of uPA mRNA, we treated Beas2B cells with cycloheximide (CycD), anisomycin, emitine and puromycin in a time-dependent manner and measured uPA mRNA expression by Northern blotting. All these agents induced uPA mRNA by two- to seven-fold within 3 h after treatment in Beas2B cells. CycD, emitine, puromycin and anisomycin also enhanced uPA mRNA half-life by three- to five-fold in Beas2B cells treated with DRB, an inhibitor of transcription. However, run-on-transcription experiments indicated that these agents failed to induce uPA mRNA transcription indicating that they augment uPA mRNA mainly due to increased stability. Using gel mobility shift, we identified an uPA mRNA binding protein (uPA mRNABp) that selectively binds to uPA mRNA [Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis In vitro. J Clin Invest 93: 1380–1387, 1994]. Binding of both cytoplasmic and nuclear uPA mRNABp to uPA mRNA was abolished after treatment with translation inhibitors, which coincides with the maximal expression of uPA mRNA. We also found a similar decline in HuR and heterogeneous nuclear ribonucleoprotein C (hnRNPC) which are known to stabilize uPA mRNA both in the nuclear and cytosolic compartments. These results strongly suggest that increased uPA mRNA stability induced by translational inhibitors involves the interaction of uPA mRNA with a degrading protein factor rather than increased interaction of proteins that are known to stabilize uPA mRNA. These data also strongly suggests that down-regulation of the uPA-uPA mRNABp interaction by translational inhibitors rather than the translocation of uPA mRNABp contributes to increased uPA mRNA stability. This pathway may regulate uPA-mediated functions of the lung epithelium in the context of inflammation or neoplasia. (Mol Cell Biochem 271: 13–22, 2005)
Similar content being viewed by others
Abbreviations
- Bronchial epithelial cells:
-
Beas2B
- tumor necrosis factor alpha:
-
TNF-α
- transforming growth factor-beta:
-
TGF-β
- heterogeneous Nuclear Ribonucleoprotein C:
-
hnRNPC
- cycloheximide D:
-
CycD
- messenger mRNA binding protein:
-
mRNABp
- urokinase-type plasminogen activator:
-
uPA
- ribonucleic acid:
-
RNA
- fetal calf serum:
-
FCS
- sodium dodecyl sulfate:
-
SDS
- polyacrylamide gel electrophoresis:
-
PAGE
- free probe:
-
Fp
- untranslated region:
-
UTR
References
Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 931380–1387, 1994
Gyetko MR, Sitrin RG, Fuller JA, Todd III RF, Petty H, Standiford TJ: Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leuk Biol 58533–538, 1995
Dumler I, Weis A, Mayboroda OA et al.: The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 273(1): 315–321, 1998
Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR: Urokinase receptor is associated with the components of JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272(45): 28563–28567, 1997
Chapman H: Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9: 714–724, 1997
Shetty S, Idell S: Posttranscriptional regulation of urokinase mRNA: Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J Biol Chem 27513771–13779, 2000
Altus MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. J Biol Chem 26621190–21196, 1991
Akashi M, Shaw G, Gross M, Saito, M, Koeffler HP: Role of AUUU sequences in stabilization of granulocyte-macrophage colony-stimulating factor RNA in stimulated cells. Blood 782005–2012, 1991
Caput D, Beutler B, Hortog K, Thayer R, Brown-Shimer, S, Cerami: A Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 831670–1674, 1986
Shaw G, Kamen RA: conserved AU sequence from the 3′untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46659–667, 1986
Jones TR, Cole MD: Rapid cytoplasmic turnover of c-myc mRNA; requirement of the 3′untanslated sequences. Mol Cell Biol 74513–4521, 1987
Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR: Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci USA 95, 6296–6301, 1998
Nanbu R, Menoud P-A, Nagamine Y: Multiple instability-regulating sites in the 3′untranslated region of the urokinase-type plasminogen activator mRNA. Mol Cell Biol 144920–4928, 1994
Heaton JH, Tillman-Bogush M, Leff NS, Gelehrter TD: Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. J Biol Chem 273, 14261–14268, 1998
Tillman-Bogush M, Heaton JH, Gelehrter TD: Cyclic nucleotide regulation of PAI-1 mRNA stability Identification of cytosolic proteins that interact with an A-Rich sequence. J Biol Chem 2741172–1179, 1999
Maurer F, Tiernay M, Medcalf RL: An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucl Acid Res 271664–1673, 1999
Wilson T, Triesman R: Removal of poly (A) and consequent degradation of c-fos mRNA facilitated by 3′AU-rich sequences. Nature 336396–399, 1988
Casey JL, Koeller DM, Ramin VC, Klausner RD, Harford JB: Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J 123693–3699, 1989
Mullner EW, Kuhn LC: A stem-loop in the 3′untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53815–825, 1988
Levine BJ, Chodchoy N, Marzluff WF, Skoultchi AI: Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc Natl Acad Sci 846189–6193, 1987
Iwai Y, Akahane K, Cohen, RB: Ca ionophore A23187-dependent stabilization of granulocyte-macrophage colony-stimulating factor messenger RNA in murine thymoma EL-4 cells is mediated through two distinct regions in the 3′-untranslated region. J Immunol 1504386–4394, 1993
Parkar R, Jacobson A: Translation and a 42-nucleotide segment within the coding region of the mRNA encoded by the MATα1 gene are involved in promoting rapid mRNA decay in yeast. Proc Natl Acad Sci USA 872780–2784, 1990
Shetty S, Kumar A, Idell S: Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 171075–1083, 1997
Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P: urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a posttranscriptional mechanism. FEBS Lett 508379–384, 2001
Tiernay M, Medcalf RL: Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. J Biol Chem 27613675–13684, 2001
Davis CA, Monnier JM, Nick HS: A coding region determinant of instability regulates levels of manganese superoxide dismutase mRNA. J Biol Chem 27637317–37326, 2001
Altus, MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J Biol Chem 26621190–21196, 1991
Ziegler A, Knesel J, Fabbro D, Nagamine Y: Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem 26621067–21074, 1991
Henderson BR, McDonald DA, Kefford RF: Posttranscriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells. Int J Cancer 50918–923, 1992
Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF: Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in mestatic tumor cells. Cancer Res 522489–2496, 1992
Shetty S, Idell S: Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 27624549–24556, 2001
Shetty S, Bdeir K Cines D, Idell S: Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 27818124–18131, 2003
Antalis TM, Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucl Acid Res 194301, 1991
Shetty S: Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol Cell Biochem 23755–67, 2002
Tran H, Maurer F, Nagamine Y: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated kinase 2. Mol Cell Biol 237177–7188, 2003
Nanbu R, Montero, L., D’Orazio D, Nagamine Y: Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1, cells down-regulated for protein kinase C. Eur J Biochem 247169–174, 1997
Marshall BC, Xu Q-P, Rao NV, Brown BR, Hoidal JR: Pulmonary epithelial Cell urokinase-type plasminogen activator. J Biol Chem 26711462–11469, 1990
Saksel O: Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 82335–65, 1985
Blasi F, Vassali JD, Dano K: Urokinase-type plasminogen activatorProenzyme, receptor, and inhibitors. J Biol Chem 104801–804, 1987
Wang Z, Kiledjian M: Identification of erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage EMBO J 19295–305, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shetty, S. Protein synthesis and urokinase mRNA metabolism. Mol Cell Biochem 271, 13–22 (2005). https://doi.org/10.1007/s11010-005-3453-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-3453-x